rheumatoid arthritis

Syndicate content

Pen Injectors Becoming Dominant Force in Many Therapeutic Sectors

Greystone Associates Assessment Identifies a Number of Therapy Areas Where Pens are Achieving Double-Digit Growth

Get the full story...

Regional Factors Add Complexity to Autoimmune Disease Drug Development

Applied Data Research Survey Examines Evolving Technology and Strategic Factors

Get the full story...

New guidelines for treating rheumatoid arthritis

Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB).

Get the full story...

Could arthritis wonder drugs provide clues for all disease?

Drugs that have helped treat millions of rheumatoid arthritis sufferers may hold the key to many more medical conditions, including atherosclerosis – a leading cause of heart disease – says the researcher who jointly invented and developed them.

Get the full story...

Heavy birthweight babies twice as likely to develop rheumatoid arthritis

Heavy birthweight female babies are twice as likely to develop rheumatoid arthritis in adulthood as their average birthweight peers, suggests research published ahead of print in the Annals of the Rheumatic Diseases.

Get the full story...

Oily fish can protect against rheumatoid arthritis

New data presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France, show that intake of oily fish is associated with a reduced risk of developing rheumatoid arthritis (RA), whereas psychosocial work stress and smoking can increase the risk of developing the condition.

Get the full story...

CV risk management should be mandatory in Rheumatoid arthritis

Rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients should undergo compulsory cardiovascular (CV) risk management and existing CV risk calculators should be adapted to the increased CV risk in inflammatory rheumatic disease patients, the EULAR Task Force on 'Cardiovascular Risk Management in RA' recommended today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Get the full story...

Rheumatoid arthritis factors equal to cardiovascular factors in risk of cardiovascular events

Certain cardiovascular disease (CVD) risk factors and rheumatoid arthritis (RA) disease factors have a similar effect on an RA patient's risk of experiencing myocardial infarction (MI) or stroke, according to a new study presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Get the full story...

Rheumatoid arthritis is risk factor for cardiovascular disease

The risk of cardiovascular disease (CVD) for people with rheumatoid arthritis (RA) has been found to be comparable to the risk of CVD in people with type 2 diabetes, according to the conclusions of two studies presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Get the full story...

Early life infections increase risk of rheumatoid arthritis

Infections during the first year of life are a marker of increased risk of developing specific types of arthritis later in life, according to new research from Sweden presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Get the full story...

Novel DNA microarray chip predicts functional impairment in rheumatoid arthritis

A new DNA microarray chip can predict severe disability and remission in patients with rheumatoid arthritis (RA), as presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Get the full story...

New insight into RA patient priorities, motivators for clinical trial involvement

Two new initiatives designed to improve the management of rheumatoid arthritis through patient participation were presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Get the full story...